Skip to main content
Veterinary Medicines

Betafuse 1 mg/g + 5 mg/g gel for dogs

Authorised
  • Betamethasone valerate
  • Fusidic acid hemihydrate

Product identification

Medicine name:
Betafuse 1 mg/g + 5 mg/g gel for dogs
Betafuse 1 mg/g + 5 mg/g, gel per cani
Active substance:
  • Betamethasone valerate
  • Fusidic acid hemihydrate
Target species:
  • Dog
Route of administration:
  • Topical use

Product details

Active substance and strength:
  • Betamethasone valerate
    1.21
    milligram(s)
    /
    1.00
    gram(s)
  • Fusidic acid hemihydrate
    10.17
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Gel
Withdrawal period by route of administration:
  • Topical use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD07CC01
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • White polyethylene coated aluminium tubes of 30 g closed with a polypropylene cap.
  • White polyethylene coated aluminium tubes of 15 g closed with a polypropylene cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Manufacturing Limited
  • Norbrook Laboratories Limited
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104942
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0558/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 19/12/2022

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."